Hepion Pharmaceuticals, Inc

/Hepion Pharmaceuticals, Inc

Follow-on

Hepion Pharmaceuticals, Inc

Biopharmaceutical

FOLLOW-ON OFFERING: We are a biopharmaceutical company headquartered in Edison, New Jersey, focused on the development of pleiotropic drug therapy for treatment of chronic liver disease.

Symbol

HEPA

Last Closing Price
$2.89

Shares
10,000,000

Anticipated Date
November 25, 2020

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Hepion Pharmaceuticals, Inc, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277